BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36690321)

  • 1. Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells.
    Liu H; Yan J; Guan F; Jin Z; Xie J; Wang C; Liu M; Liu J
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Apr; 1868(4):159287. PubMed ID: 36690321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploratory Data Analysis of Cell and Mitochondrial High-Fat, High-Sugar Toxicity on Human HepG2 Cells.
    Amorim R; Simões ICM; Veloso C; Carvalho A; Simões RF; Pereira FB; Thiel T; Normann A; Morais C; Jurado AS; Wieckowski MR; Teixeira J; Oliveira PJ
    Nutrients; 2021 May; 13(5):. PubMed ID: 34069635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin targets ferroptosis through bimodal alteration of redox environment and cellular pathways in NAFLD model.
    Saha M; Das S; Manna K; Saha KD
    Biosci Rep; 2023 Oct; 43(10):. PubMed ID: 37728565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the attenuated effect of Ginkgolide B on ferroptosis in high fat diet induced nonalcoholic fatty liver disease.
    Yang Y; Chen J; Gao Q; Shan X; Wang J; Lv Z
    Toxicology; 2020 Dec; 445():152599. PubMed ID: 32976958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
    Im AR; Kim YH; Lee HW; Song KH
    J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation.
    Jin M; Feng H; Wang Y; Yan S; Shen B; Li Z; Qin H; Wang Q; Li J; Liu G
    Oxid Med Cell Longev; 2020; 2020():2940746. PubMed ID: 32655764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
    Kim DE; Chang BY; Jeon BM; Baek JI; Kim SC; Kim SY
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630596
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Bae S; Lee YH; Lee J; Park J; Jun W
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558538
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview of ferroptosis in non-alcoholic fatty liver disease.
    Wang S; Liu Z; Geng J; Li L; Feng X
    Biomed Pharmacother; 2022 Sep; 153():113374. PubMed ID: 35834990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
    Hong Y; Choi SI; Hong E; Kim GH
    J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of the Y220C mutant p53 against steatosis: good news?
    Gori M; Barbaro B; Arciello M; Maggio R; Viscomi C; Longo A; Balsano C
    J Cell Physiol; 2014 Sep; 229(9):1182-92. PubMed ID: 24395441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.
    Xiao J; Bei Y; Liu J; Dimitrova-Shumkovska J; Kuang D; Zhou Q; Li J; Yang Y; Xiang Y; Wang F; Yang C; Yang W
    J Cell Mol Med; 2016 Feb; 20(2):204-16. PubMed ID: 26648452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferroptosis resistance cooperates with cellular senescence in the overt stage of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Vetuschi A; Cappariello A; Onori P; Gaudio E; Latella G; Pompili S; Sferra R
    Eur J Histochem; 2022 Jun; 66(3):. PubMed ID: 35726536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the regulation of iron homeostasis as a potential therapeutic strategy for nonalcoholic fatty liver disease.
    Sui Y; Geng X; Wang Z; Zhang J; Yang Y; Meng Z
    Metabolism; 2024 Jun; 157():155953. PubMed ID: 38885833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isosteviol Protects Free Fatty Acid- and High Fat Diet-Induced Hepatic Injury
    Yi H; Xu D; Wu X; Xu F; Lin L; Zhou H
    Antioxid Redox Signal; 2019 Jun; 30(17):1949-1968. PubMed ID: 30484323
    [No Abstract]   [Full Text] [Related]  

  • 17. Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4.
    Zhu Z; Zhang Y; Huang X; Can L; Zhao X; Wang Y; Xue J; Cheng M; Zhu L
    Eur J Pharmacol; 2021 Oct; 908():174351. PubMed ID: 34280397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hesperetin ameliorates hepatic oxidative stress and inflammation
    Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
    Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.
    Wang L; Sun M; Cao Y; Ma L; Shen Y; Velikanova AA; Li X; Sun C; Zhao Y
    Arch Biochem Biophys; 2020 Nov; 695():108642. PubMed ID: 33098868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of metformin against palmitate-induced hepatic cell death.
    Geng Y; Hernández Villanueva A; Oun A; Buist-Homan M; Blokzijl H; Faber KN; Dolga A; Moshage H
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165621. PubMed ID: 31786336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.